Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Exploring the Different COVID Tests

On this episode of HealthFirst Talks, host Grace Huang welcomes two medical expert guests to discuss the different COVID-19 tests, their efficacy, and what test to use in different scenarios. Those guests are Dr. Scott Cohen, Chief Medical Information Officer and Chief Performance Improvement Officer for Bassett Healthcare Network, and Dr. Fiona Collins, dentist and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from HealthFirst on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

On this episode of HealthFirst Talks, host Grace Huang welcomes two medical expert guests to discuss the different COVID-19 tests, their efficacy, and what test to use in different scenarios. Those guests are Dr. Scott Cohen, Chief Medical Information Officer and Chief Performance Improvement Officer for Bassett Healthcare Network, and Dr. Fiona Collins, dentist and international speaker and author.

Drs. Cohen and Collins explained the two types of COVID-19 tests: PCR tests and antigen tests. “There are two broad types of COVID-19 diagnostic tests. The antigen test takes the nasal fluid and looks for the presence of the antigen. If so, it’s positive. The PCR is looking for the presence of coronavirus RNA,” Dr. Cohen said.

Which is more accurate? Dr. Collins explained, “When looking at accuracy, diagnostic tests can be high sensitivity or high specificity. With high sensitivity, you have very few false negatives. With high specificity, very few false positives.”

The doctors agreed that false negatives were more concerning for COVID-19. With a false positive, the worst that could happen is isolation. A false negative could lead to spread.

When looking at the two tests, Dr. Collins shared, “PCR tests have high specificity and sensitivity. Antigen is only high specificity. It can have a false-negative rate of 15-20%.”

With this in mind, PCR testing is clearly the stronger test, but it may not always be the best choice. For post-exposure testing, Collins said, “PCR is more reliable, but it will take a few days to get back, so patients should quarantine until results.”

In the case of mass testing, the antigen test may be better because it acts as a monitoring system, and people are being tested regularly. “Antigen testing is fastest and least expensive. No lab is needed. Because you’re regular testing, you can overcome the sensitivity issue,” Dr. Cohen added.

Learn more about COVID testing and precautions to take by watching the conversation.

HealthFirst

Part of this channel

HealthFirst

Practice-ready solutions for dental and medical offices nationwide.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Jessica Davison - Assistant Vice President of Strategy, Learning & Analytics, United Way of Greater Houston

Jessica Davison - Assistant Vice President of Strategy, Learning & Analytics, United Way of Greater Houston

Jessica Davison serves as the Assistant Vice President of Strategy, Learning & Analytics at United Way of Greater Houston. The article focuses on her strategic role and initiatives in analytics within the organization. The context is in the healthcare industry, with insights pertaining to Texas.

  • 01Jessica Davison is the Assistant Vice President of Strategy, Learning & Analytics at United Way of Greater Houston.
  • 02The article discusses strategic roles and analytics initiatives within healthcare.
  • 03The focus is on the healthcare industry in Texas.

Aug 25, 2026

Epic’s MyChart phishing wave is pushing patient-access teams to treat portal identity as a security perimeter

Epic’s MyChart phishing wave is pushing patient-access teams to treat portal identity as a security perimeter

Hospitals are alerting patients about phishing scams involving Epic’s MyChart, as these scams impersonate the patient portal to deceive users. The concern grows as CMS encourages healthcare innovation and interoperability. As a response, healthcare teams are treating portal identity as a vital security frontier.

  • 01Hospitals are experiencing phishing scams that mimic Epic’s MyChart portal.
  • 02The CMS continues to push for industry-led pledges toward healthcare interoperability.
  • 03Patient portal identity is being prioritized as a critical aspect of cybersecurity.

Aug 25, 2026

Adonis’ new CPO and first CRO signals AI RCM vendors are shifting from pilots to platform operating models

Adonis’ new CPO and first CRO signals AI RCM vendors are shifting from pilots to platform operating models

Adonis has appointed a new Chief Product Officer (CPO) and promoted its first Chief Revenue Officer (CRO), following a successful $40 million Series C funding round and a fourfold increase in revenue. This move underscores a shift among AI RCM vendors, like Adonis, from pilot projects to platform-based operating models. This transition is expected to result in more structured product roadmaps and a strong emphasis on value demonstration for health systems.

  • 01Adonis appointed a new CPO and promoted its first CRO.
  • 02The company achieved a $40 million Series C funding and a fourfold revenue increase.
  • 03AI RCM vendors are moving from pilot projects to platform operating models.

Aug 22, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512